Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice

Vaccine

Volumn 24, Issue 19, 2006, Pages 4179-4187

  Estevan, Maite ^a   Gamazo, Carlos ^a   Grilló, María Jesús ^b   del Barrio, Guillermo García ^a   Blasco, Jose M ^b   Irache, Juan M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto Agroalimentario de Aragón IA2   (Spain)

Author keywords

Adjuvant; Brucella melitensis; Brucellosis; Microparticles; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BETA CYCLODEXTRIN; BRUCELLA VACCINE; EXCIPIENT; LIVE VACCINE; POLOXAMER; POLYCAPROLACTONE; POLYSORBATE 20; POLYSORBATE 80; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; BACTERIAL STRAIN; BRUCELLA MELITENSIS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; EVAPORATION; FEMALE; INFECTION PREVENTION; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLVENT EXTRACTION; ZETA POTENTIAL;

ANIMALS; ANTIGENS, BACTERIAL; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; EXCIPIENTS; FEMALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYESTERS; VACCINES, SUBUNIT;

EID: 33646121957     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.038     Document Type: Article

References (38)

1. Hoover D.L., Nikolich M.P., Izadjoo M.J., Borschel R.H., and Bhattacharjee A.K. Development of new Brucella vaccines by molecular methods. In: López-Goñi I., and Moriyón I. (Eds). Brucella: molecular and cellular biology (2004), Horizon Bioscience, Norfolk 369-402
2. Blasco J.M. Brucella ovis. In: Nelson K., and Duncan J.R. (Eds). Animal brucellosis. (1990), CRC Press, Florida, Boca Raton 9-12
3. Jiménez de Bagüés M.P., Marín C.M., Barberán M., and Blasco J.M. Responses of ewe to B. melitensis Rev1 vaccine administered by subcutaneous or conjuntival routes at different stages of pregnancy. Ann Rech Vet 20 2 (1989) 205-213
4. Alton G.G., and Elberg S.S. Rev1 Brucella melitensis vaccine: a review of ten years of study. Vet Bull 371 (1967) 793-800
5. Blasco J.M. A review of the use of B. melitensis Rev1 vaccine in adult sheep and goats. Prev Vet Med 31 3-4 (1997) 275-283
6. Meyer M.E. Characterization of Brucella abortus strain 19 isolated from human and bovine tissues and fluids. Am J Vet Res 46 (1985) 902-904
7. MacMillan A.P. Conventional serological tests. In: Nielsen K.H., and Duncan J.R. (Eds). Animal brucellosis (1990), CRC Press, Florida, Boca Raton 153-197
8. Ariza J., Gudiol F., Pallares R., Rufi G., and Fernández-Viladrich P. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother 28 4 (1985) 548-551
9. Moriyón I., Grilló M.J., Monreal D., González D., Marín C., López-Goñi I., et al. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res 35 (2004) 1-38
10. Jiménez de Bagüés M.P., Barberán M., Marín C.M., and Blasco J.M. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine 13 (1995) 301-304
11. el Idrisi A.H., Benkirame A., el Maadoudi M., Bouslikhane M., Berrada J., and Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Technol 20 3 (2001) 741-747
12. Murillo M., Grilló M.J., Reñé J., Marín C.M., Barberán M., Goñi M.M., et al. A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice. Vaccine 19 30 (2001) 4099-4106
13. Murillo M., Goñi M.M., Irache J.M., Arangoa M.A., Blasco J.M., and Gamazo C. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. J Control Release 85 (2002) 237-246
14. Murillo M., Irache J.M., Estevan M., Goñi M.M., Blasco J.M., and Gamazo C. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis. Int J Pharm 271 (2004) 125-135
15. Muñoz MP, Estevan M, Marín CM, De Miguel MJ, Grilló M., Barberán M, et al. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. Vaccine, in press.
16. Gamazo C., Winter A.J., Moriyón I., Riezu-Boj J.I., Blasco J.M., and Díaz R. Comparative analysis of proteins extracted by hot saline or release spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun 57 5 (1989) 1419-1426
17. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
18. Osborn M.J. Studies on the gram-negative cell-wall. I. Evidence for the role of 2-keto-3-deoxy-octonate in the lipopolysaccharide of Salmonella typhimurium. Proc Natl Acad Sci USA 50 (1963) 499-506
19. García del Barrio G., Novo F.J., and Irache J.M. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties. J Control Release 86 (2003) 123-130
20. Yeh M.K., Liu Y.T., Chen J.L., and Chiang C.H. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles. J Control Release 82 (2002) 237-247
21. Estevan M, Gamazo C, González-Gaitano G, Irache JM. Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery. J Microencapsul, in press.
22. Chou D.K., Krishnamurthy R., Randolph T.W., Carpenter J.F., and Manning M.C. Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation. J Pharm Sci 94 6 (2005) 1368-1381
23. + Th1 cells. Vaccine 13 (1995) 1741-1749
24. Conway M.A., Madrigal-Estebas L., McClean S., Brayden D.J., and Mills K.H.G. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine 19 15-16 (2001) 1940-1950
25. Berkland C., Kipper M.J., Narasimhan B., Kyekyoon K., and Pack D.W. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release 94 (2003) 129-141
26. Benoit M.A., Baras B., and Gillard J. Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 184 (1999) 73-84
27. Bibby D.C., Davies N.M., and Tucker I.G. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm 197 (2000) 1-11
28. Victor S.P., and Sharma C.P. Stimuli sensitive polymethacrylic acid microparticles (PMAA)-oral insulin delivery. J Biomater Appl 17 2 (2002) 125-134
29. De Rosa G., Larobina D., La Rotonda M.I., Musto P., Quaglia F., and Ungaro F. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-β-cyclodextrin system. J Control Release 102 (2005) 71-83
30. Diwan M., and Park T.G. Pegylation enhances protein stability during encapsulation in PLGA microspheres. J Control Release 73 2-3 (2001) 233-244
31. Cleland J.L., and Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm Res 13 (1996) 1464-1475
32. Tobío M., Nolley J., Guo Y., McIver J., and Alonso M.J. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm Res 16 5 (1999) 682-688
33. Morita T., Sakamura Y., Horikiri Y., Suzuki T., and Yoshino H. Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres. Eur J Pharm Biopharm 51 (2001) 45-53
34. Kang F., Jiang G., Hinderliter A., DeLuca P.P., and Singh J. Lysozyme stability in primary emulsification for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients. Pharm Res 19 (2002) 629-633
35. Sah H. Stabilization of proteins against methylene chloride/water interphase-induced denaturation and aggregation. J Control Release 58 (1999) 143-151
36. Duchêne D., Bochot A., Yu S.C., Pépin C., and Seiller M. Cyclodextrins and emulsions. Int J Pharm 266 (2003) 85-90
37. Bilati U., Allemann E., and Doelker E. Strategic approaches for overcoming peptide and protein stability within biodegradable nano- and microparticles. Eur J Pharm Biopharm 59 3 (2005) 375-388
38. van de Weert M., Hoechstetter W.E., Hennink W.E., and Crommelin D.J. The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release 68 (2000) 351-359